Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
Circulation
    July 2026
  1. HUMBERT M, Zeder K, Kovacs G, Weatherald J, et al
    Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.
    Circulation. 2026;154:156-177.
    >> Share

    June 2026
  2. NGUYEN M, AlEssa HB, Glenn AJ, Tobias DK, et al
    Consumption of Fructose-Containing Food and Beverage Sources in Childhood Through to Adulthood and Risk of Hypertension: A Prospective Cohort Study.
    Circulation. 2026 Jun 22:10.1161/CIRCULATIONAHA.125.077666.
    >> Share

  3. ALKHODARI M, Lapidaire W, Kart T, Xiong Z, et al
    Contrastive Machine Learning to Quantify Hypertensive Multiorgan Damage and Identify New Disease Phenotypes: A Multinational Multimodal Study.
    Circulation. 2026 Jun 21. doi: 10.1161/CIRCULATIONAHA.125.077394.
    >> Share

  4. WANG Q, Tian J, Liu D, Zheng T, et al
    Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension.
    Circulation. 2026 Jun 10. doi: 10.1161/CIRCULATIONAHA.125.066183.
    >> Share

    May 2026
  5. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
    Correction to: Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
    Circulation. 2026;153:e1362.
    >> Share

  6. HOU Y, Li Q, Wei TW, Lin X, et al
    Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways.
    Circulation. 2026 May 26. doi: 10.1161/CIRCULATIONAHA.124.073606.
    >> Share

  7. SARMA S, Chin KM
    Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026;153:1460-1462.
    >> Share

  8. LI R, Tang Y, Ding Y, Hu P, et al
    GPRASP1 Safeguards Endothelial Aspartate Metabolism to Prevent Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026 May 7. doi: 10.1161/CIRCULATIONAHA.126.079030.
    >> Share

    April 2026
  9. FARMER N, Wei Y, Albin JL
    Culinary Medicine as a Key Lever in Hypertension Management.
    Circulation. 2026;153:1083-1085.
    >> Share

  10. SARFO FS, Akpalu A, Bockarie AS, Nguah SB, et al
    Phone-Based Intervention Under Nurse Guidance for Control of Hypertension After Stroke: A Randomized Multicenter Phase 3 Trial in Ghana.
    Circulation. 2026 Apr 9. doi: 10.1161/CIRCULATIONAHA.125.077424.
    >> Share

  11. PULLAMSETTI SS, Vanderpool RR, de Man F, de Jesus Perez VA, et al
    Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Apr 2. doi: 10.1161/CIR.0000000000001422.
    >> Share

    March 2026
  12. GARRY JD, Brittain EL
    Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data.
    Circulation. 2026;153:980-982.
    >> Share

  13. FORBES LM, Cornwell WK
    Group 1 Pulmonary Hypertension With Elevated Pulmonary Artery Wedge Pressure: Characterizing A Complex Phenotype.
    Circulation. 2026;153:963-966.
    >> Share

  14. GOMBERG-MAITLAND M, Tedford RJ, Langleben D, Rosenkranz S, et al
    Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study.
    Circulation. 2026 Mar 29. doi: 10.1161/CIRCULATIONAHA.126.079918.
    >> Share

  15. ZHANG Y, Bonnet S, Provencher S, Piao J, et al
    A Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension.
    Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.078674.
    >> Share

    February 2026
  16. SHOREY-KENDRICK LE, Ladd-Acosta C, Zhao H, Aschner JL, et al
    Association of Maternal Smoking During Pregnancy With Childhood Blood Pressure and Hypertension in the ECHO Cohort.
    Circulation. 2026;153:536-539.
    >> Share

  17. BOYER TM, Barrett RB, Xiong C, Bu F, et al
    Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women.
    Circulation. 2026;153:480-492.
    >> Share

  18. REDDY YNV, Frantz RP, Miranda WR, Asokan AK, et al
    Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.077606.
    >> Share

  19. JAMBON-BARBARA C, Suissa S, Dell'Aniello S, Hlavaty A, et al
    Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.
    Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.077764.
    >> Share

    January 2026
  20. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
    Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
    Circulation. 2026 Jan 28. doi: 10.1161/CIRCULATIONAHA.125.079067.
    >> Share

  21. TADA A, Fayyaz AU, Reddy YNV, Redfield MM, et al
    Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution.
    Circulation. 2026;153:285-289.
    >> Share

  22. COHEN JB, Jones DW, Flack JM
    From Race-Based to Equity-Informed Antihypertensive Medication Selection: Rationale for the 2025 AHA/ACC Guideline Change.
    Circulation. 2026;153:137-139.
    >> Share

    December 2025
  23. LI F, Poudel B, Andrade-Silva M, Wu J, et al
    Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage.
    Circulation. 2025 Dec 11:10.1161/CIRCULATIONAHA.124.071351.
    >> Share

    October 2025
  24. CAI A, Bayes-Genis A, Ryan J, Feng Y, et al
    Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial.
    Circulation. 2025 Oct 22. doi: 10.1161/CIRCULATIONAHA.125.076263.
    >> Share

  25. LIU J, Zhang L, Chen Z
    Letter by Liu et al Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e285-e286.
    >> Share

  26. HUANG J
    Letter by Huang Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e289-e290.
    >> Share

  27. JOHNSTON A, Edwards JD, Coutinho T
    Response by Johnston et al to Letters Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e291-e292.
    >> Share

  28. FAUCHIER L, Lochon L, Lip GYH
    Letter by Fauchier et al Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e287-e288.
    >> Share

  29. KORNELIUS E
    Letter by Kornelius Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e284.
    >> Share

    September 2025
  30. JONES DW, Ferdinand KC, Taler SJ, Johnson HM, et al
    2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Commit
    Circulation. 2025;152:e114-e218.
    >> Share

    August 2025
  31. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
    >> Share

    June 2025
  32. ZHANG F, Zhong Y
    Letter by Zhang and Zhong Regarding Article, "Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis".
    Circulation. 2025;151:e1072.
    >> Share

  33. VUKADINOVIC D, Lauder L, Mahfoud F
    Response by Vukadinovic et al to Letter Regarding Article, "Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis".
    Circulation. 2025;151:e1073-e1074.
    >> Share

  34. WANG J, Yuan Z, Yu N, Jiao Q, et al
    Inactivation of RhoA for Hypertension Treatment Through the TRPV4-RhoA-RhoGDI1 Axis.
    Circulation. 2025 Jun 16. doi: 10.1161/CIRCULATIONAHA.124.071884.
    >> Share

  35. KIM HK, Fukazawa A, Smith SA, Mizuno M, et al
    High Dietary Phosphate Intake Induces Hypertension and Sympathetic Overactivation Through Central Fibroblast Growth Factor Receptor Signaling.
    Circulation. 2025 Jun 5. doi: 10.1161/CIRCULATIONAHA.124.071605.
    >> Share

    April 2025
  36. YU Q, Tai YY, Tang Y, Zhao J, et al
    Correction to: BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
    Circulation. 2025;151:e967.
    >> Share

  37. AGRAWAL V, Hemnes AR
    Integrin Targeting Therapies in Pulmonary Arterial Hypertension: A Roadmap for Traversing the Translational Valley of Death?
    Circulation. 2025;151:1184-1186.
    >> Share

  38. SINGH R, Kulthinee S, Nasci VL, Akwo EA, et al
    G-Protein-Coupled Estrogen Receptor 1 and Pregnancy Confer Protection Against Hypertension in Older Females.
    Circulation. 2025;151:1126-1129.
    >> Share

  39. HONG J, Medzikovic L, Sun W, Wong B, et al
    Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
    Circulation. 2025;151:e921.
    >> Share

  40. CAO N, Lan C, Chen C, Xu Z, et al
    Correction to: Prenatal Lipopolysaccharides Exposure Induces Transgenerational Inheritance of Hypertension.
    Circulation. 2025;151:e866.
    >> Share

    March 2025
  41. NIIRANEN TJ, Schnabel RB, Schutte AE, Biton Y, et al
    Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration.
    Circulation. 2025;151:863-877.
    >> Share

  42. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2025;151:e763.
    >> Share

  43. VONGPATANASIN W, Turcu AF
    The Journey of Resistant Hypertension: From the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure to American Heart Association/American College of Cardiology Guidelines.
    Circulation. 2025;151:653-655.
    >> Share

  44. DAI H, Lu X, Zhou X
    Letter by Dai et al Regarding Article, "Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction".
    Circulation. 2025;151:e686.
    >> Share

    February 2025
  45. YU AYX, Auger N, Fu L, Chu A, et al
    Population-Level Screening for Diabetes and Dyslipidemia After Pregnancies Complicated by Hypertension or Diabetes.
    Circulation. 2025;151:508-510.
    >> Share

  46. COUNTOURIS M, Mahmoud Z, Cohen JB, Crousillat D, et al
    Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care.
    Circulation. 2025;151:490-507.
    >> Share

  47. JOHNSTON A, Petrcich W, Smith GN, Fell DB, et al
    Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study.
    Circulation. 2025 Feb 11. doi: 10.1161/CIRCULATIONAHA.124.072418.
    >> Share

  48. KRESS TC, Barris CT, Kovacs L, Khakina BN, et al
    CD4(+) T Cells Expressing Viral Proteins Induce HIV-Associated Endothelial Dysfunction and Hypertension Through Interleukin 1alpha-Mediated Increases in Endothelial NADPH Oxidase 1.
    Circulation. 2025 Feb 5. doi: 10.1161/CIRCULATIONAHA.124.070538.
    >> Share

    January 2025
  49. HOEPER MM, Haughie S, Hassan T, Vogt S, et al
    Response by Hoeper et al to Letter Regarding Article, "Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults with Pulmonary Arterial Hypertension".
    Circulation. 2025;151:e32.
    >> Share

  50. YAN P, Zhang M, Cao Y
    Letter by Yan et al Regarding Article, "Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension".
    Circulation. 2025;151:e31.
    >> Share

  51. LEMAY SE, Montesinos MS, Grobs Y, Yokokawa T, et al
    Exploring Integrin alpha5beta1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies.
    Circulation. 2025 Jan 20. doi: 10.1161/CIRCULATIONAHA.124.070693.
    >> Share

    December 2024
  52. LAFFIN LJ
    Future of Antihypertensive Therapies.
    Circulation. 2024;150:1987-1989.
    >> Share

    November 2024
  53. ZHANG M, Pan X, Zhu X
    Letter by Zhang et al Regarding Article, "Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era".
    Circulation. 2024;150:e467.
    >> Share

  54. MCLAUGHLIN VV, Humbert M
    Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic Interventions.
    Circulation. 2024;150:1653-1655.
    >> Share

    October 2024
  55. BARONE GIBBS B, Perera S, Huber KA, Paley JL, et al
    Effects of Sedentary Behavior Reduction on Blood Pressure in Desk Workers: Results From the RESET-BP Randomized Clinical Trial.
    Circulation. 2024;150:1416-1427.
    >> Share

  56. DELCROIX M, Pepke-Zaba J, D'Armini AM, Fadel E, et al
    Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.
    Circulation. 2024;150:1354-1365.
    >> Share

  57. VUKADINOVIC D, Lauder L, Kandzari DE, Bhatt DL, et al
    Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis.
    Circulation. 2024 Oct 2. doi: 10.1161/CIRCULATIONAHA.124.069709.
    >> Share

  58. GIANNOPOULOS AA, Gimelli A
    Unveiling the Hidden Layers of Hypertensive Heart Disease Through Quantitative PET Imaging.
    Circulation. 2024;150:1087-1089.
    >> Share

    September 2024
  59. JIANG X, Mahfoud F, Li W, Dong H, et al
    Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.
    Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069215.
    >> Share

    August 2024
  60. HONG J, Medzikovic L, Sun W, Wong B, et al
    Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069864.
    >> Share

  61. XU X, Divakaran S, Weber BN, Hainer J, et al
    Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With Hypertension.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.123.067083.
    >> Share

  62. ZHANG Z, Liu K, Chen X
    Letter by Zhang et al Regarding Article, "Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program".
    Circulation. 2024;150:e181-e182.
    >> Share

    July 2024
  63. LIU B, Yi D, Xia X, Ramirez K, et al
    General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2alpha/Notch4 Pathway.
    Circulation. 2024;150:414-417.
    >> Share

  64. COOPER LA, Marsteller JA, Carson KA, Dietz KB, et al
    Equitable Care for Hypertension: Blood Pressure and Patient-Reported Outcomes of the RICH LIFE Cluster Randomized Trial.
    Circulation. 2024;150:230-242.
    >> Share

    June 2024
  65. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069340.
    >> Share

  66. ZHANG Q, Yaoita N, Tabuchi A, Liu S, et al
    Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
    Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.124.068726.
    >> Share


  67. Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1412.
    >> Share

    May 2024
  68. SALAHUDDIN A, Harris IS, Sabanayagam A
    Double Whammy Complicating Management of Pulmonary Hypertension.
    Circulation. 2024;149:1770-1774.
    >> Share

  69. JHENG JR, Bai Y, Noda K, Huot JR, et al
    Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
    >> Share

  70. HOEPER MM, Ewert R, Jansa P, Sirenko Y, et al
    Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
    Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.123.068107.
    >> Share

  71. RUBIN LJ
    Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?
    Circulation. 2024;149:1565-1567.
    >> Share

  72. HARING B, Andrews CA, Hovey K, Shadyab AH, et al
    Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative.
    Circulation. 2024;149:1568-1577.
    >> Share

  73. TANG H, Gupta A, Morrisroe SA, Bao C, et al
    Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
    Circulation. 2024 May 2. doi: 10.1161/CIRCULATIONAHA.123.065304.
    >> Share

    April 2024
  74. BORDAN Z, Batori R, Haigh S, Li X, et al
    PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.067095.
    >> Share

  75. RAO RJ, Chan SY
    Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
    Circulation. 2024;149:1372-1374.
    >> Share

  76. GERHARDT F, Fiessler E, Olsson KM, Kayser MZ, et al
    Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Circulation. 2024 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.063821.
    >> Share

  77. KANDZARI DE, Weber MA, Pathak A, Zidar JP, et al
    Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results from the TARGET BP I Randomized Clinical Trial.
    Circulation. 2024 Apr 8. doi: 10.1161/CIRCULATIONAHA.124.069291.
    >> Share

  78. SHEN H, Gao Y, Ge D, Tan M, et al
    BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
    Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.066430.
    >> Share

    March 2024
  79. PETER JG, Ntusi NAB, Ntsekhe M
    Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?
    Circulation. 2024;149:804-806.
    >> Share

  80. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    >> Share

    February 2024
  81. REDING KW, Jordan JH
    Multimodal Imaging Evidence for Optimized Blood Pressure Control Following Hypertensive Pregnancy: Mechanistic Insights Into Beneficial Cardiac Remodeling From the POP-HT Trial.
    Circulation. 2024;149:542-544.
    >> Share

  82. PITT B, Williams GH
    Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?
    Circulation. 2024;149:414-416.
    >> Share

  83. LUO Y, Qi X, Zhang Z, Zhang J, et al
    Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.
    Circulation. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579.
    >> Share

    January 2024
  84. BIAN JS, Chen J, Zhang J, Tan J, et al
    ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
    Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
    >> Share

    December 2023
  85. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    >> Share

  86. REAY WR, Clarke E, Eslick S, Riveros C, et al
    Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension.
    Circulation. 2023 Dec 22. doi: 10.1161/CIRCULATIONAHA.123.065394.
    >> Share

  87. RASMUSSEN SB, Jeppesen KK, Kjaergaard J, Hassager C, et al
    Blood Pressure and Oxygen Targets on Kidney Injury After Cardiac Arrest.
    Circulation. 2023;148:1860-1869.
    >> Share

    November 2023
  88. HUNDEMER GL, Agharazii M, Madore F, Vaidya A, et al
    Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066389.
    >> Share

  89. WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
    Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1825-1826.
    >> Share

  90. LI G, Chen H, Ren C
    Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1823-1824.
    >> Share

  91. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    >> Share

  92. KITT J, Krasner S, Barr L, Frost A, et al
    Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Sub-study.
    Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067597.
    >> Share

    October 2023
  93. AZIZI M, Sharp ASP, Fisher NDL, Weber MA, et al
    Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months Following Medication Escalation: The RADIANCE Clinical Trial Program.
    Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.066941.
    >> Share

  94. OSTROMINSKI JW, Vaduganathan M, Selvaraj S, Claggett BL, et al
    Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065254.
    >> Share

    September 2023
  95. KUEHN BM
    Experimental Drug, Combination Pill Show Promise for Treating Pulmonary Hypertension.
    Circulation. 2023;148:852-854.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016